Lub wechat account ntawm Yuecang Pharmaceutical YOUCARE tau hais tias: Tsis ntev los no, Yuecang Pharmaceutical's broad-spectrum coronavirus membrane fusion inhibitor polypeptide (YKYYO17 aerosol inhaler) tau pom zoo los ntawm National Medical Products Administration rau kev sim tshuaj. YKYY017 atomized inhaler yog chav kawm 1 tshuaj tshiab tshuaj tsim los ntawm peb lub tuam txhab nrog lub tswv yim meej ntawm kev ua, cov nyhuv curative thiab ua tiav cov tswv cuab kev txawj ntse. Daim ntawv thov no yog rau kev kho mob ntawm tus kab mob coronavirus tshiab.
Kev pom zoo rau kev kho mob ntawm nebulized inhalant yog qhov tseem ceeb heev. Peptide tshuaj inhalation npaj yog ib qho kev npaj siab kawg, uas paub txog kev siv cov tshuaj peptide kom zoo los ntawm kev nqus cov pa hauv lub ntsws, kom cov tshuaj peptide tuaj yeem ua rau muaj txiaj ntsig zoo, thiab muaj kev cia siab rau kev siv dav.
YKYY017 aerosol inhaler yog cov tiam tshiab ntawm dav-spectrum thiab muaj txiaj ntsig zoo ntawm tus mob coronavirus membrane fusion inhibitor sib koom ua ke tsim los ntawm Yuegang Pharmaceutical thiab Institute of Pathogenic Biology, Suav Academy ntawm Kev Kho Mob Sciences. Nws tuaj yeem ua lub luag haujlwm tiv thaiv kab mob los ntawm inhibiting membrane fusion pathways ntawm cell nto thiab endocytic lub cev. Yuegang Pharmaceutical muaj lub ntiaj teb tshwj xeeb txoj cai ntawm YKYY017.
Tam sim no, COVID-19 qhov xwm txheej tshwm sim hauv tsev thiab txawv teb chaws tseem hnyav heev, thiab muaj kev xav tau sai rau kev tiv thaiv thiab tswj cov khoom lag luam zoo. Cov tshuaj kho mob YKYY017 atomizing inhalant yog cov khoom lag luam uas muaj cov cai muaj tswv yim ywj pheej thiab tuaj yeem siv los kho tus kab mob coronavirus tshiab, uas yuav pab tiv thaiv tib neeg lub neej thiab kev noj qab haus huv.
